
Agents were informed that they would no longer receive commissions for select signs up as of November 1.
Mike Hollan is an assistant managing editor for Pharmaceutical Executive and Medical Device and Technology and can be reached at mhollan@mjhlifesciences.com.

Agents were informed that they would no longer receive commissions for select signs up as of November 1.

How will President Trump’s return to office impact the pharma industry?

Padraic Ward discusses the innovation-environment in Europe.

David Reddy discusses negotiations on the global pandemic accord.

Amgen CEO Robert A. Bradway discusses the potential impact of the election, and politics in general, will have on the industry.

Abi Carter is timing the partnership with the release of her upcoming album.

The healthcare company signed a deal with Infirmary Health, who services customers in Georgia and parts of Florida and Mississippi.

The executive director of patient strategies & solutions discusses J&J’s new Guide to Expanded Access.

The alliance’s president discusses the current state of data sharing, security concerns, and the adoption AI.

The president of compliance services discusses the company’s recent expansion into new markets.

The CEO discusses the current state of compounding pharmacies and how it built to this point.

Abrysvo had previously been approved for adults 60-years and older.

The current phase of the campaign is focused on family conversations during holiday gatherings.

The meeting is set to focus on advancing smoking cessation.

The gallery will be presented at the HLTH 2024 conference.

The guidelines, titled BRIDGE, are set to be released in 2025.

People suffering from the condition reportedly struggle to find public restrooms in emergencies.

The study, released by Otsuka, reveals that caregivers perform the work of highly paid professionals.

The company includes the technology in drug development, improving efficiency, and other areas.

Sun Life U.S. teamed up with several other Florida-based companies to provide needed assistance in areas impacted by the recent storms.

The organization hopes to collect data to provide better education around Thrombosis.

Slope’s CEO and co-founder discusses technological advances that are solving problems with data collection and sorting from clinical trials.

Dr. Sandra Lee is joining the educational program, which originally launched last year.

Industry leaders gather to discuss different ways life sciences organizations can champion their environmentally-conscious younger employees while combatting still-entrenched public mistrust.

S-HiCon can reportedly achieve stable liquid formulation for over 200 mg/mL subcutaneous administration.

MedHub has been expanded to work with a wider variety of insurance plans.

Rafaat Rahmani, president and founder of Lifescience Dynamics, grew up in abject poverty, but such hardships—and a later violent brush with racism—would ultimately end up fueling a determined and entrepreneurial path in the life sciences.

Roaldi previously served as chief growth officer for UnitedHealthcare Community & State.

Respondents showed concern for cost increases and changes to benefits.

The campaign comes during a time when the nation is facing a blood shortage.